Muto Y - Search Results

1

Both insulin sensitivity and glucose sensitivity are impaired in patients with non-diabetic liver cirrhosis.

Kato M, Asano H, Miwa Y, Tajika M, Yamato M, Tomita E, Tokuyama K, Muto Y, Moriwaki H. Kato M, et al. Among authors: muto y. Hepatol Res. 2000 May;17(2):93-101. doi: 10.1016/s1386-6346(99)00065-0. Hepatol Res. 2000. PMID: 10707003

2

[Impaired metabolism of amino acid and protein in patients with liver cirrhosis].

Kato M, Moriwaki H, Muto Y. Kato M, et al. Among authors: muto y. Nihon Rinsho. 1994 Jan;52(1):145-9. Nihon Rinsho. 1994. PMID: 8114284 Japanese.

3

Preferential use of branched-chain amino acids as an energy substrate in patients with liver cirrhosis.

Kato M, Miwa Y, Tajika M, Hiraoka T, Muto Y, Moriwaki H. Kato M, et al. Among authors: muto y. Intern Med. 1998 May;37(5):429-34. doi: 10.2169/internalmedicine.37.429. Intern Med. 1998. PMID: 9652895 Free article.

4

Improvement of fuel metabolism by nocturnal energy supplementation in patients with liver cirrhosis.

Miwa Y, Shiraki M, Kato M, Tajika M, Mohri H, Murakami N, Kato T, Ohnishi H, Morioku T, Muto Y, Moriwaki H. Miwa Y, et al. Among authors: muto y. Hepatol Res. 2000 Nov;18(3):184-189. doi: 10.1016/s1386-6346(99)00100-x. Hepatol Res. 2000. PMID: 11058823

5

Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis.

Yoshida T, Muto Y, Moriwaki H, Yamato M. Yoshida T, et al. Among authors: muto y. Gastroenterol Jpn. 1989 Dec;24(6):692-8. doi: 10.1007/BF02774169. Gastroenterol Jpn. 1989. PMID: 2606303

6

Determination of the integrated CT number of the whole liver in patients with severe hepatitis: as an indicator of the functional reserve of the liver.

Kumahara T, Muto Y, Moriwaki H, Yoshida T, Tomita E. Kumahara T, et al. Among authors: muto y. Gastroenterol Jpn. 1989 Jun;24(3):290-7. doi: 10.1007/BF02774327. Gastroenterol Jpn. 1989. PMID: 2744345

7

Effects of branched-chain amino acid infusion on protein metabolism in rats with acute hepatic failure.

Miwa Y, Kato M, Moriwaki H, Okuno M, Sugihara J, Ohnishi H, Yoshida T, Muto Y, Nakayama M, Morioka Y, et al. Miwa Y, et al. Among authors: muto y. Hepatology. 1995 Jul;22(1):291-6. Hepatology. 1995. PMID: 7601423

8

[Recent advances in the treatment of decompensated liver cirrhosis].

Moriwaki H, Kato M, Murase M, Muto Y. Moriwaki H, et al. Among authors: muto y. Nihon Rinsho. 1994 Jan;52(1):192-6. Nihon Rinsho. 1994. PMID: 8114292 Japanese.

9

Oral supplementation with branched-chain amino acids improves transthyretin turnover in rats with carbon tetrachloride-induced liver cirrhosis.

Usui T, Moriwaki H, Hatakeyama H, Kasai T, Kato M, Seishima M, Okuno M, Ohnishi H, Yoshida T, Muto Y. Usui T, et al. Among authors: muto y. J Nutr. 1996 May;126(5):1412-20. doi: 10.1093/jn/126.5.1412. J Nutr. 1996. PMID: 8618138 Free article.

10

Treatment with a novel lipid A analogue, FS-112, and partial hepatectomy causes submassive liver necrosis and impaired liver regeneration in mice.

Maeda T, Ohnishi H, Hayashi T, Ishiki Y, Moriwaki H, Muto Y. Maeda T, et al. Among authors: muto y. J Gastroenterol Hepatol. 1996 May;11(5):471-7. doi: 10.1111/j.1440-1746.1996.tb00293.x. J Gastroenterol Hepatol. 1996. PMID: 8743920 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,008 results

Search Page

Filters